— Know what they know.
Not Investment Advice

SILO NASDAQ

Silo Pharma, Inc.
1W: -16.6% 1M: -41.6% 3M: -76.5% YTD: +335.0% 1Y: +113.0% 3Y: -15.6% 5Y: +689.2%
$1.46
-0.04 (-2.80%)
 
Weekly Expected Move ±8.0%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 27 · $1.6M mcap · 1M float · 14.23% daily turnover · Short 53% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
35.1 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 645.1%
Cost Advantage ★
41
Intangibles
37
Switching Cost
31
Network Effect
39
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SILO has No discernible competitive edge (35.1/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 645.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Oct 02, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SILO receives an overall rating of C+. Strongest factors: DCF (5/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-04-27 C C+
2026-04-22 C+ C
2026-03-30 C C+
2026-03-27 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
0
Earnings Quality
47
Growth
36
Value
40
Momentum
40
Safety
0
Cash Flow
41

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-2.93
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
0.09
Bankruptcy prob: 52.1%
High Risk
Credit Rating
BB-
Score: 37.3/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.75x
Accruals: -18.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SILO scores -2.93, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SILO scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SILO's implied 52.1% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SILO receives an estimated rating of BB- (score: 37.3/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.27x
PEG
-0.00x
P/S
30.43x
P/B
0.33x
P/FCF
-2.04x
P/OCF
—
EV/EBITDA
-0.30x
EV/Revenue
25.69x
EV/EBIT
-0.30x
EV/FCF
-0.42x
Earnings Yield
-65.55%
FCF Yield
-48.96%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. SILO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.974
EBT / EBIT
×
EBIT Margin
-84.896
EBIT / Rev
×
Asset Turnover
0.009
Rev / Assets
×
Equity Multiplier
1.286
Assets / Equity
=
ROE
-91.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SILO's ROE of -91.2% is driven by Asset Turnover (0.009), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1440 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.46
Median 1Y
$0.14
5th Pctile
$0.00
95th Pctile
$6.37
Ann. Volatility
227.7%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Eric Weisblum,
Chief Executive Officer
$350,000 $— $630,051
Daniel Ryweck, Financial
ancial Officer
$60,000 $— $88,600

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $630,051
Avg Employee Cost (SGA/emp): $435,293
Employees: 3

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3
0.0% YoY
Revenue / Employee
$24,034
Rev: $72,102
Profit / Employee
$-1,409,233
NI: $-4,227,698
SGA / Employee
$435,293
Avg labor cost proxy
R&D / Employee
$720,276
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 49.2% 43.1% 66.5% 69.3% -30.3% -40.3% -46.9% -56.5% -43.8% -44.8% -48.8% -49.3% -53.0% -78.4% -99.4% -90.0% -86.1% -74.6% -99.9% -91.2% -91.23%
ROA 43.8% 37.2% 55.6% 57.4% -27.3% -35.3% -40.6% -47.3% -38.5% -38.2% -40.0% -38.4% -43.1% -58.0% -72.0% -66.6% -67.9% -1.1% -75.0% -71.0% -70.96%
ROIC 1.9% 2.3% 2.7% 2.6% 4.9% 2.8% 2.5% 2.1% 2.7% 2.0% 2.1% 1.8% 2.6% 1.8% 2.7% 3.1% 4.6% 6.1% 6.4% 6.5% 6.45%
ROCE -17.0% -29.4% -28.0% -32.0% -25.9% -37.1% -43.3% -52.7% -54.0% -52.0% -58.0% -51.2% -49.3% -77.3% -99.3% -88.4% -90.5% 9.7% -76.1% -94.0% -93.95%
Gross Margin 91.9% 91.9% 91.9% 91.9% 91.9% 91.9% 91.9% 91.9% 91.9% 91.9% 91.9% 91.9% 91.9% -21.2% 91.9% 91.9% -12.9% -14.8% -13.8% — —
Operating Margin -25.7% -52.3% -33.4% -27.4% -52.7% -91.9% -44.6% -61.9% -42.9% -64.6% -48.8% -55.6% -56.0% -104.1% -60.7% -69.3% -63.9% -43.6% -88.5% — —
Net Margin 354.2% -60.4% -33.5% -36.5% -54.5% -92.2% -50.3% -56.2% -36.6% -62.2% -44.5% -51.7% -51.5% -96.0% -57.2% -66.8% -61.6% -48.9% -91.4% — —
EBITDA Margin -27.4% -58.6% -33.4% -36.5% -54.5% -106.2% -50.2% -56.1% -36.6% -58.3% -44.4% -51.6% -51.3% -99.4% -56.9% -66.6% -61.4% -46.9% -91.0% — —
FCF Margin -28.3% -32.0% -38.1% -36.4% -47.0% -48.5% -47.2% -49.2% -44.4% -44.7% -46.7% -49.3% -53.1% -53.2% -64.3% -72.0% -66.6% -64.6% -53.3% -61.8% -61.77%
OCF Margin -28.3% -32.0% -38.1% -36.4% -47.0% -48.5% -47.2% -49.2% -44.4% -44.7% -46.7% -49.3% -53.1% -53.2% -64.3% -72.0% -66.6% -64.6% -53.3% -61.8% -61.77%
ROE 3Y Avg snapshot only -83.36%
ROE 5Y Avg snapshot only -50.77%
ROA 3Y Avg snapshot only -64.15%
ROIC Economic snapshot only -72.15%
Cash ROA snapshot only -56.12%
NOPAT Margin snapshot only -65.18%
Pretax Margin snapshot only -82.70%
R&D / Revenue snapshot only 39.97%
SGA / Revenue snapshot only 33.59%
SBC / Revenue snapshot only 2.57%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 0.08 0.07 0.10 0.05 -3.23 -1.84 -1.58 -1.42 -1.22 -1.13 -1.55 -0.87 -1.25 -0.91 -1.14 -0.81 -1.27 -0.07 -0.07 -1.53 -0.272
P/S Ratio 7.30 3.85 5.75 3.03 149.29 99.84 92.00 89.67 72.00 58.04 77.54 42.34 65.63 55.35 72.77 54.87 89.30 4.19 4.56 126.15 30.429
P/B Ratio 0.04 0.03 0.05 0.03 0.91 0.70 0.70 0.78 0.69 0.68 1.06 0.51 0.70 0.79 1.31 0.80 1.29 0.05 0.06 1.40 0.328
P/FCF -0.26 -0.12 -0.15 -0.08 -3.18 -2.06 -1.95 -1.82 -1.62 -1.30 -1.66 -0.86 -1.24 -1.04 -1.13 -0.76 -1.34 -0.06 -0.09 -2.04 -2.042
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA 5.67 3.39 3.41 3.07 0.47 1.00 0.91 0.73 0.80 0.96 0.33 1.32 0.89 0.69 0.04 0.47 -0.10 1.57 1.24 -0.30 -0.303
EV/Revenue -200.84 -140.08 -124.79 -119.67 -21.74 -57.85 -56.17 -48.86 -49.64 -48.27 -16.00 -63.19 -45.54 -42.85 -2.84 -31.95 6.94 -90.94 -82.46 25.69 25.688
EV/EBIT 5.67 3.39 3.41 3.07 0.47 1.00 0.91 0.73 0.80 0.96 0.33 1.32 0.89 0.69 0.04 0.47 -0.10 1.56 1.24 -0.30 -0.303
EV/FCF 7.11 4.38 3.27 3.29 0.46 1.19 1.19 0.99 1.12 1.08 0.34 1.28 0.86 0.81 0.04 0.44 -0.10 1.41 1.55 -0.42 -0.416
Earnings Yield 12.8% 14.2% 10.2% 18.4% -31.0% -54.3% -63.5% -70.6% -81.7% -88.4% -64.3% -1.2% -80.0% -1.1% -88.1% -1.2% -78.8% -14.0% -14.7% -65.6% -65.55%
FCF Yield -3.9% -8.3% -6.6% -12.0% -31.5% -48.6% -51.3% -54.9% -61.6% -77.0% -60.3% -1.2% -80.9% -96.1% -88.4% -1.3% -74.5% -15.4% -11.7% -49.0% -48.96%
Price/Tangible Book snapshot only 1.459
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 39.88 21.23 32.85 33.28 41.36 26.52 14.96 9.09 13.14 9.90 7.87 5.84 7.91 4.29 4.73 6.07 8.70 11.36 9.65 5.36 5.361
Quick Ratio 39.88 21.23 32.85 33.28 41.36 26.52 14.96 9.09 13.14 9.90 7.87 5.84 7.91 4.29 4.73 6.07 8.70 11.36 9.65 5.36 5.361
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Net Debt/Equity -1.09 -1.13 -1.11 -1.12 -1.04 -1.10 -1.13 -1.20 -1.17 -1.24 -1.27 -1.28 -1.18 -1.41 -1.36 -1.27 -1.19 -1.09 -1.10 -1.11 -1.112
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.000
Net Debt/EBITDA 5.88 3.49 3.57 3.15 3.74 2.73 2.39 2.07 1.95 2.11 1.92 2.21 2.16 1.59 1.17 1.27 1.16 1.64 1.31 1.19 1.186
Interest Coverage -656.49 -969.14 -1562.88 -4346.42 -20130.72 -1891.34 -1157.47 -841.97 -660.69 -744.76 -692.62 -677.19 -729.64 -875.63 -886.61 -977.31 -1053.72 -112.34 -124.45 -115.27 -115.274
Equity Multiplier 1.12 1.16 1.14 1.15 1.10 1.13 1.17 1.24 1.20 1.25 1.31 1.35 1.26 1.47 1.47 1.35 1.27 0.03 1.24 1.22 1.218
Cash Ratio snapshot only 5.098
Debt Service Coverage snapshot only -115.053
Defensive Interval snapshot only 498.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.009
Inventory Turnover — — 0.26 0.21 — — — — — — — — — — — — — — — — —
Receivables Turnover — — — — — 2.18 2.15 2.11 2.07 2.18 2.15 2.11 2.07 — — — — — — — —
Payables Turnover 0.02 0.01 0.03 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.35 0.73 0.36 0.81 0.25 0.62 0.81 0.807
DSO 0 0 0 0 0 167 170 173 176 167 170 173 176 0 0 0 0 0 0 0 0.0 days
DIO 0 0 1396 1738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 21761 30485 12310 10877 13596 24451 25511 37638 25956 33377 20641 71864 49373 1033 503 1006 449 1438 591 452 452.3 days
Cash Conversion Cycle -21761 -30485 -10914 -9139 -13596 -24284 -25341 -37465 -25780 -33210 -20471 -71691 -49197 -1033 -503 -1006 -449 -1438 -591 -452 -452.3 days
Cash Velocity snapshot only 0.010
Capital Intensity snapshot only 110.066
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — 3.2% 1.0% 35.4% 1.2% -0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -25.0% -25.00%
Net Income — — 5.5% 3.9% -1.7% -2.0% -2.0% -2.1% -27.2% 5.3% 14.6% 23.0% 10.8% -18.7% -28.6% -39.3% -34.2% 3.8% -4.8% 8.6% 8.65%
EPS — — 4.9% 3.8% -1.7% -1.9% -1.6% -1.7% 18.1% 30.2% 5.9% 20.5% 35.6% 23.1% 17.8% 32.3% 38.1% -3.9% -4.1% -4.2% -4.22%
FCF — — -7.6% -2.1% -1.3% -53.5% -23.8% -35.2% 5.5% 7.8% 0.9% -0.0% -19.6% -18.9% -37.6% -46.1% -25.4% -21.6% 17.1% 35.6% 35.63%
EBITDA — — -1.9% -1.0% -75.1% -41.4% -69.2% -71.2% -36.0% 12.8% 21.1% 28.5% 17.5% -22.6% -32.7% -43.7% -38.3% 6.0% -2.6% 7.3% 7.29%
Op. Income — — -1.7% -87.1% -65.9% -34.9% -59.6% -80.7% -45.5% -4.1% -0.7% 15.6% 6.7% -23.7% -26.8% -36.9% -32.4% 10.3% 4.1% 14.7% 14.69%
OCF Growth snapshot only 35.63%
Asset Growth snapshot only -10.53%
Equity Growth snapshot only -0.63%
Shares Change snapshot only -82.51%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — 61.3% 27.0% 10.6% 0.4% -0.0% 0.0% 0.0% 0.0% 0.0% -9.1% -9.14%
Revenue 5Y — — — — — — — — — — — — — — — — — — 33.2% 9.0% 8.96%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — 58.7% 26.0% 10.1% — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — 8.1% 17.1% -9.1% -10.9% -15.3% -9.7% -21.2% -73.5% -14.0% -16.6% -16.56%
Assets 5Y — — — — — — — — — — — — — — — — — — 5.0% 3.5% 3.53%
Equity 3Y — — — — — — — — — — 7.8% 16.5% -12.6% -17.8% -22.2% -14.5% -25.0% -15.2% -15.6% -16.2% -16.17%
Book Value 3Y — — — — — — — — — — -9.4% 0.1% -32.3% -38.1% -40.8% -41.7% -55.1% 13.7% 27.6% 19.1% 19.14%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — 0.75 0.75 0.75 0.75 0.60 0.60 0.60 0.60 0.60 1.00 1.00 1.00 0.66 0.25 0.253
Earnings Stability — — — — — — 0.15 0.13 0.82 0.73 0.30 0.25 0.64 0.65 0.43 0.39 0.62 0.55 0.48 0.41 0.411
Margin Stability — — — — — — 0.97 0.99 0.99 0.99 0.98 0.99 0.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — 0.20 0.20 0.50 0.50 0.50 0.50 0.96 0.93 0.89 0.84 0.86 0.98 0.98 0.97 0.965
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — -0.58 -0.62 -0.67 -0.63 -0.71 -0.57 -0.13 -0.38 -0.59 -0.43 -0.45 0.07 0.06 -0.12 -0.122
Gross Margin Trend — — — — — — -0.02 -0.01 -0.01 -0.01 0.00 0.00 0.00 -5.53 -5.53 -5.53 -8.98 -0.96 -4.63 -7.15 -7.154
FCF Margin Trend — — — — — — -18.83 -19.10 -6.78 -4.48 -4.10 -6.42 -7.40 -6.56 -17.34 -22.72 -17.82 -15.70 2.21 -1.15 -1.151
Sustainable Growth Rate 49.2% 43.1% 66.5% 69.3% — — — — — — — — — — — — — — — — —
Internal Growth Rate 78.0% 59.3% 1.3% 1.3% — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -0.30 -0.58 -0.65 -0.65 1.02 0.89 0.81 0.78 0.75 0.87 0.94 1.01 1.01 0.87 1.00 1.06 0.95 1.10 0.79 0.75 0.747
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.747
CapEx/Revenue 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.01%
CapEx/Depreciation snapshot only 0.001
Accruals Ratio 0.57 0.59 0.92 0.95 0.00 -0.04 -0.08 -0.11 -0.09 -0.05 -0.03 0.00 0.00 -0.07 0.00 0.04 -0.04 0.11 -0.15 -0.18 -0.180
Sloan Accruals snapshot only -0.109
Cash Flow Adequacy snapshot only -556709.167
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.0% 5.3% 11.3% 10.5% 16.8% 7.8% 4.3% 1.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -9.8% -13.8% 0.0% 0.0% -45.9% -68.6% -74.5% -74.4% 5.3% 11.3% 10.5% -38.0% -64.4% -81.2% -64.0% -96.9% -42.4% -16.1% -14.8% -40.6% -40.55%
Total Shareholder Return -9.8% -13.8% 0.0% 0.0% -45.9% -68.6% -74.5% -74.4% 5.3% 11.3% 10.5% -38.0% -64.4% -81.2% -64.0% -96.9% -42.4% -16.1% -14.8% -40.6% -40.55%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.95 0.93 0.95 0.97 1.01 1.00 1.00 1.00 1.00 1.02 1.02 1.02 1.02 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) -2.78 -1.42 -1.69 -1.48 1.00 0.94 0.94 0.95 0.94 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 1.01 1.01 0.97 0.974
EBIT Margin -35.41 -41.29 -36.57 -39.00 -45.79 -57.68 -61.87 -66.76 -62.26 -50.29 -48.84 -47.71 -51.44 -61.74 -64.93 -68.71 -71.23 -58.12 -66.64 -84.90 -84.896
Asset Turnover 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.009
Equity Multiplier 1.12 1.16 1.20 1.21 1.11 1.14 1.16 1.19 1.14 1.17 1.22 1.28 1.23 1.35 1.38 1.35 1.27 0.67 1.33 1.29 1.286
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $2.50 $2.03 $2.14 $2.03 $-1.67 $-1.82 $-1.33 $-1.45 $-1.36 $-1.27 $-1.25 $-1.15 $-0.88 $-0.98 $-1.03 $-0.78 $-0.54 $-4.76 $-5.30 $-4.07 $-4.07
Book Value/Share $5.09 $4.72 $4.31 $3.96 $5.92 $4.83 $2.99 $2.63 $2.41 $2.13 $1.85 $1.95 $1.58 $1.12 $0.89 $0.78 $0.54 $7.10 $6.22 $4.45 $4.45
Tangible Book/Share $5.09 $4.72 $4.31 $3.96 $5.92 $4.83 $2.99 $2.63 $2.41 $2.13 $1.85 $1.87 $1.52 $1.07 $0.84 $0.75 $0.51 $6.86 $5.98 $4.26 $4.26
Revenue/Share $0.03 $0.04 $0.04 $0.04 $0.04 $0.03 $0.02 $0.02 $0.02 $0.02 $0.03 $0.02 $0.02 $0.02 $0.02 $0.01 $0.01 $0.08 $0.08 $0.05 $0.05
FCF/Share $-0.75 $-1.19 $-1.39 $-1.32 $-1.69 $-1.63 $-1.08 $-1.13 $-1.03 $-1.11 $-1.18 $-1.16 $-0.89 $-0.85 $-1.03 $-0.83 $-0.51 $-5.25 $-4.21 $-3.04 $-3.04
OCF/Share $-0.75 $-1.19 $-1.39 $-1.32 $-1.69 $-1.63 $-1.08 $-1.13 $-1.03 $-1.11 $-1.18 $-1.16 $-0.89 $-0.85 $-1.03 $-0.83 $-0.51 $-5.25 $-4.21 $-3.04 $-3.04
Cash/Share $5.56 $5.35 $4.77 $4.45 $6.16 $5.31 $3.38 $3.17 $2.82 $2.64 $2.35 $2.49 $1.86 $1.58 $1.22 $1.00 $0.64 $7.72 $6.87 $4.95 $4.95
EBITDA/Share $-0.95 $-1.53 $-1.34 $-1.41 $-1.65 $-1.94 $-1.41 $-1.53 $-1.44 $-1.25 $-1.23 $-1.13 $-0.86 $-0.99 $-1.04 $-0.79 $-0.55 $-4.71 $-5.24 $-4.17 $-4.17
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-5.56 $-5.35 $-4.77 $-4.45 $-6.16 $-5.31 $-3.38 $-3.17 $-2.82 $-2.64 $-2.35 $-2.49 $-1.86 $-1.58 $-1.22 $-1.00 $-0.64 $-7.72 $-6.87 $-4.95 $-4.95
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -2.927
Altman Z-Prime snapshot only -5.374
Piotroski F-Score 2 2 5 5 2 2 1 1 2 2 3 3 2 2 1 2 3 4 4 3 3
Beneish M-Score — — 1.94 1.44 -2.33 -2.88 -3.03 -3.31 -3.30 -3.67 -3.55 -1.46 -1.82 -1.76 -0.70 -2.28 -3.33 -258.07 -3.75 — —
Ohlson O-Score snapshot only 0.086
ROIC (Greenblatt) snapshot only -98.78%
Net-Net WC snapshot only $4.23
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB-
Credit Score 38.79 34.88 36.37 36.84 69.84 54.24 47.63 42.41 42.74 38.11 37.86 37.78 37.60 37.28 37.43 37.64 37.40 36.87 37.41 37.29 37.286
Credit Grade snapshot only 13
Credit Trend snapshot only -0.357
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 31
Sector Credit Rank snapshot only 29

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms